GSK Lifts Outlook as Earnings Rise
Wall Street Journal
GSK raised its full-year guidance after second quarter core earnings rose 13%, helped by higher sales in oncology, HIV and its general medicines portfolio.
https://www.wsj.com/articles/gsk-lifts-guidance-after-higher-turnover-beats-market-views-f0043426